Using AI to improve imaging for pulmonary embolism diagnosis
CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study
This study is testing if using advanced imaging and artificial intelligence can help doctors diagnose and manage pulmonary embolism better for patients who might have it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 14 Years and up |
| Sex | All |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06526468 on ClinicalTrials.gov |
What this trial studies
The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study in China that aims to enhance the diagnosis and management of pulmonary embolism (PE) through advanced imaging techniques and artificial intelligence. By collecting and analyzing imaging data from patients suspected of PE, the study seeks to identify key imaging markers that can aid in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment. The study focuses on the critical stages of PE, including acute pulmonary embolism, chronic thromboembolic pulmonary disease, and chronic thromboembolic pulmonary hypertension, to improve patient outcomes through timely intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 14 years and older who are suspected of having pulmonary embolism.
Not a fit: Patients who are pregnant, refuse follow-up, or have incomplete imaging scans may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early diagnosis and management of pulmonary embolism, potentially saving lives and enhancing patient quality of life.
How similar studies have performed: Other studies utilizing artificial intelligence for imaging in similar conditions have shown promising results, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 14 Years and older * Patients suspected of PE Exclusion Criteria: * Pregnant women * Refuse to follow up * Incomplete or discontinued imaging scans * Insufficient quality of image data to allow for analysis
Where this trial is running
Beijing
- China-Japan Frendship hospital — Beijing, China (Recruiting)
Study contacts
- Study coordinator: Min Liu, PhD
- Email: mikie0763@126.com
- Phone: +86-10-84205056
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.